Impact of Complementary Medicines on Survival in Patients with Cancer Treated with Oral Chemotherapy in an Oncology Hospital in France: Exploratory StudyImpact des Thérapies Complémentaires sur la Survie de Patients Atteints d’un Cancer Traités par Chimiothérapie Orale dans un Établissement Hospitalier Français Spécialisé en Oncologie : Étude Exploratoire-Reference-Cited by-同舟云学术

Impact of Complementary Medicines on Survival in Patients with Cancer Treated with Oral Chemotherapy in an Oncology Hospital in France: Exploratory StudyImpact des Thérapies Complémentaires sur la Survie de Patients Atteints d’un Cancer Traités par Chimiothérapie Orale dans un Établissement Hospitalier Français Spécialisé en Oncologie : Étude Exploratoire

Published:2022 Issue:4 Volume:24 Page:605-612
ISSN:1292-3818
Container-title:Oncologie
language:en
Short-container-title:

Author:

Ninot Gr間ory,Guerdoux Estelle,Carbonnel Fran鏾is,Faravel Kerstin,Ismael Ludovic,Leenhardt Fanny,Lognos B閍trice,Perrier Caroline,Philibert Laurent,Tronc Boris,Viala Marie

Publisher

Walter de Gruyter GmbH

Subject

Oncology

Link

https://www.techscience.com/oncologie/v24n4/51000/pdf

Reference20 articles.

1. Risk evaluation of the use of complementary and alternative medicines in cancer;Renet;Annales Pharmaceutiques Francaises,2021

2. Trends in the use of complementary health approaches among adults: United States, 2002–2012;Clarke;National Health Statistics Reports,2015

3. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology;Richardson;Journal of Clinical Oncology,2000

4. Complementary and alternative medicine in patients with breast cancer: Exploratory study of social network forum data;Lognos;Journal of Medical Internet Research,2019

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Pharmacy Initiatives Contribute to the Excellent Efficacy of the Dabrafenib/Trametinib Combination for Iodine-Refractory Thyroid Carcinoma: A Case Report;Medicina;2024-06-25